Neuroleptic therapy as an antitumor protective factor in schizophrenic patients with polysindromic framework

2020 ◽  
Vol 179 (6) ◽  
Author(s):  
Walter Filippelli ◽  
Luigi Petrillo ◽  
Annamaria Coti ◽  
Giovanni Castaldo ◽  
Francesco Lalla ◽  
...  
Keyword(s):  
Protective Factor ◽  
Neuroleptic Therapy ◽  
Schizophrenic Patients

EEG-brain mapping—A useful predictor of the efficiency of neuroleptic therapy in schizophrenic patients

1991 ◽  
Vol 4 (3) ◽  
pp. 337
Author(s):  
R. Schellenberg ◽  
W. Knorr ◽  
Angela Schwarz ◽  
M. Schindler
Keyword(s):  
Brain Mapping ◽  
Neuroleptic Therapy ◽  
Schizophrenic Patients

Calcium Metabolism in Schizophrenic Patients on Long-Term Neuroleptic Therapy

1980 ◽  
Vol 6 (1) ◽  
pp. 56-59 ◽  
Author(s):  
P.C. Baastrup ◽  
C. Christiansen ◽  
I. Transbøl
Keyword(s):  
Calcium Metabolism ◽  
Neuroleptic Therapy ◽  
Schizophrenic Patients

No Correlation between Neuroleptic-induced Increase of β-Endorphin Serum Level and Therapeutic Efficacy in Schizophrenia

1984 ◽  
Vol 144 (6) ◽  
pp. 651-653 ◽  
Author(s):  
D. Naber ◽  
N. Nedopil ◽  
E. Eben
Keyword(s):  
Statistical Analysis ◽  
Serum Level ◽  
Drug Treatment ◽  
Therapeutic Efficacy ◽  
Neuroleptic Treatment ◽  
Normal Range ◽  
Neuroleptic Therapy ◽  
Endocrine Effect ◽  
Schizophrenic Patients

SummaryIn 23 acute, unmedicated, schizophrenic patients, psychotic behaviour and β-endorphin serum level were measured before and during four weeks of neuroleptic therapy. Prior to drug treatment, β-endorphin level of all patients was within the normal range. Neuroleptic therapy induced marked elevations of β-endorphin in eight subjects; statistical analysis revealed a slight but significant increase for the whole group. This endocrine effect was not correlated with therapeutic efficacy of neuroleptic treatment.

Depressive syndromes in schizophrenic patients under neuroleptic therapy

1992 ◽  
Vol 241 (5) ◽  
pp. 291-295 ◽  
Author(s):  
B. Bandelow ◽  
P. Müller ◽  
U. Frick ◽  
W. Gaebel ◽  
M. Linden ◽  
...  
Keyword(s):  
Neuroleptic Therapy ◽  
Schizophrenic Patients ◽  
Depressive Syndromes

Increased plasma phospholipase-A2 activity in schizophrenic patients: Reduction after neuroleptic therapy

1987 ◽  
Vol 22 (4) ◽  
pp. 421-426 ◽  
Author(s):  
Wagner F. Gattaz ◽  
Manfred Köllisch ◽  
Tom Thuren ◽  
Jorma A. Virtanen ◽  
Paavo K.J. Kinnunen
Keyword(s):  
Phospholipase A2 ◽  
Neuroleptic Therapy ◽  
Schizophrenic Patients ◽  
Phospholipase A2 Activity

High-dosage Neuroleptic Therapy for Acute Schizophrenic Patients - Two Double-blind Studies with Benperidol

1985 ◽  
Vol 18 (01) ◽  
pp. 63-66 ◽  
Author(s):  
N. Nedopil ◽  
E. Eben ◽  
H. Klein ◽  
R. Krüger ◽  
E. Rüther ◽  
...  
Keyword(s):  
Double Blind ◽  
Neuroleptic Therapy ◽  
Schizophrenic Patients

The discontinuance of maintenance neuroleptic therapy in chronic schizophrenic patients: drug and social consequences

1983 ◽  
Vol 67 (5) ◽  
pp. 339-352 ◽  
Author(s):  
D. A. W. Johnson ◽  
G. Pasterski ◽  
J. M. Ludlow ◽  
K. Street ◽  
R. D. W. Taylor
Keyword(s):  
Social Consequences ◽  
Chronic Schizophrenic ◽  
Neuroleptic Therapy ◽  
Schizophrenic Patients
Sign in / Sign up

Export Citation Format

Share Document